Related Experiment Videos
Rhenium-188 microspheres: a new radiation synovectomy agent
1Department of Nuclear Medicine, Veterans General Hospital, Taichung and National Yang-Ming University, Taipei, Taiwan.
Nuclear Medicine Communications
|December 16, 1998
Summary
This study shows that rhenium-188 (188Re) microspheres are effective for radiation synovectomy, minimizing leakage from joints in arthritis treatment.
Area of Science:
- Nuclear Medicine
- Rheumatology
- Biomedical Engineering
Background:
- Radiation synovectomy effectively manages rheumatoid arthritis symptoms.
- Concerns regarding radiopharmaceutical leakage limit its clinical use.
- Particle size selection is key to minimizing leakage.
Purpose of the Study:
- To evaluate the efficacy of 188Re microspheres for radiation synovectomy.
- To assess the biodistribution and retention of 188Re microspheres after intra-articular injection.
- To determine the potential of 188Re microspheres in minimizing radiotracer leakage.
Main Methods:
- Rhenium-188 (188Re) labelled microspheres were prepared.
- Intra-articular injection of 188Re microspheres into rabbit knees with antigen-induced arthritis.
- Gamma camera imaging to quantify 188Re retention in the knee joint.
- Biodistribution analysis to assess radioactivity in organs over time.
Main Results:
- Mean retention of 188Re in the knee was high: 98.7% at 1h, 94.6% at 24h, and 93.6% at 48h.
- Biodistribution data showed negligible radioactivity in other organs.
- This indicates minimal leakage of the radiotracer from the treated joint.
Conclusions:
- 188Re microspheres demonstrate high retention within the joint.
- The study suggests 188Re microspheres are a safe and effective radiopharmaceutical for radiation synovectomy.
- This approach holds promise for improved arthritis management with reduced leakage risks.